CRISTAUDO, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 1.103
EU - Europa 128
AS - Asia 112
SA - Sud America 5
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.350
Nazione #
US - Stati Uniti d'America 1.102
SG - Singapore 89
IT - Italia 28
DE - Germania 19
RU - Federazione Russa 19
CN - Cina 14
IE - Irlanda 13
GB - Regno Unito 10
BE - Belgio 9
FR - Francia 7
UA - Ucraina 7
BR - Brasile 5
SE - Svezia 5
FI - Finlandia 4
JP - Giappone 3
CZ - Repubblica Ceca 2
HK - Hong Kong 2
BD - Bangladesh 1
CA - Canada 1
CH - Svizzera 1
EU - Europa 1
GR - Grecia 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
NL - Olanda 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 1.350
Città #
Wilmington 386
Houston 253
Woodbridge 162
Singapore 85
Chandler 42
Fairfield 38
Ashburn 23
Ann Arbor 21
Seattle 20
Cambridge 18
Santa Clara 18
Rome 16
Dublin 11
Dearborn 10
Brussels 9
Medford 8
New York 8
Munich 6
Beijing 4
Lawrence 4
São Paulo 4
Jacksonville 3
Kunming 3
Palo Alto 3
San Francisco 3
Brno 2
Helsinki 2
Hong Kong 2
London 2
Milan 2
Moscow 2
San Diego 2
Almaty 1
Amsterdam 1
Bratislava 1
Caserta 1
Guangzhou 1
Hebei 1
Hounslow 1
Jinan 1
Johannesburg 1
Kilburn 1
Kraków 1
Los Angeles 1
Nanchang 1
Nanjing 1
Norwalk 1
Redmond 1
Redwood City 1
Saint Petersburg 1
Seoul 1
Thessaloníki 1
Tokyo 1
Toronto 1
Xian 1
Totale 1.195
Nome #
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 444
Integrase strand transfer inhibitor-based regimen is related with a limited HIV-1 V3 loop evolution in clinical practice 305
Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14 298
Naïve/Effector CD4 T cell ratio as a useful predictive marker of immune reconstitution in late presenter HIV patients: A multicenter study 180
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 25
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Na{\"i}ve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004?2014 24
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 24
Brief Report: Drop in CD4+ Counts Below 200 Cells/μL After Reaching (or Starting From) Values Higher than 350 Cells/μL in HIV-Infected Patients With Virological Suppression 23
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 23
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 16
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 16
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA <50~cp/mL 13
Totale 1.391
Categoria #
all - tutte 3.719
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.719


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020304 0 0 0 0 25 34 52 44 46 36 30 37
2020/2021277 29 36 28 41 25 33 33 33 2 8 3 6
2021/202259 7 4 1 4 0 4 5 2 8 7 5 12
2022/202396 22 10 5 14 8 14 6 8 5 2 1 1
2023/202458 4 1 0 0 2 8 1 0 2 35 0 5
2024/2025182 12 103 43 20 4 0 0 0 0 0 0 0
Totale 1.391